BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17546582)

  • 1. Persistent and remodeling hepatic preneoplastic lesions present differences in cell proliferation and apoptosis, as well as in p53, Bcl-2 and NF-kappaB pathways.
    Mazzantini RP; de Conti A; Moreno FS
    J Cell Biochem; 2008 Feb; 103(2):538-46. PubMed ID: 17546582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-ionone inhibits persistent preneoplastic lesions during the early promotion phase of rat hepatocarcinogenesis: TGF-α, NF-κB, and p53 as cellular targets.
    Scolastici C; de Conti A; Cardozo MT; Ong TP; Purgatto E; Horst MA; Heidor R; Furtado KS; Bassoli BK; Moreno FS
    Nutr Cancer; 2014; 66(2):234-41. PubMed ID: 24364727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents.
    Gillet R; Grimber G; Bennoun M; Caron de Fromentel C; Briand P; Joulin V
    Oncogene; 2000 Jul; 19(31):3498-507. PubMed ID: 10918608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain.
    De Miglio MR; Simile MM; Muroni MR; Pusceddu S; Calvisi D; Carru A; Seddaiu MA; Daino L; Deiana L; Pascale RM; Feo F
    Mol Carcinog; 1999 May; 25(1):21-9. PubMed ID: 10331741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-kappaB activation.
    de Moura Espíndola R; Mazzantini RP; Ong TP; de Conti A; Heidor R; Moreno FS
    Carcinogenesis; 2005 Jun; 26(6):1091-9. PubMed ID: 15718255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats.
    Khan MS; Devaraj H; Devaraj N
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):85-94. PubMed ID: 21167192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of Bcl-2 family genes in basal and D-amphetamine-induced apoptosis in preneoplastic and neoplastic rat liver lesions.
    De Miglio MR; Muroni MR; Simile MM; Calvisi DF; Tolu P; Deiana L; Carru A; Bonelli G; Feo F; Pascale RM
    Hepatology; 2000 Apr; 31(4):956-65. PubMed ID: 10733553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemopreventive effects of the dietary histone deacetylase inhibitor tributyrin alone or in combination with vitamin A during the promotion phase of rat hepatocarcinogenesis.
    de Conti A; Kuroiwa-Trzmielina J; Horst MA; Bassoli BK; Chagas CE; Purgatto E; Cavalher FP; Camargo AA; Jordão AA; Vannucchi H; Scolastici C; Ong TP; Moreno FS
    J Nutr Biochem; 2012 Aug; 23(8):860-6. PubMed ID: 21940155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of glutathione S-transferase P-form mRNA expression in remodeling nodules in rat liver revealed by in situ hybridization.
    Imai T; Masui T; Ichinose M; Nakanishi H; Yanai T; Masegi T; Muramatsu M; Tatematsu M
    Carcinogenesis; 1997 Mar; 18(3):545-51. PubMed ID: 9067555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to the promotion of glutathione S-transferase 7-7-positive liver lesions in Copenhagen rats.
    Wood GA; Sarma DS; Archer MC
    Carcinogenesis; 1999 Jul; 20(7):1169-75. PubMed ID: 10383886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of caffeic acid phenethyl ester analogues in a modified resistant hepatocyte model.
    Macías-Pérez JR; Beltrán-Ramírez O; Vásquez-Garzón VR; Salcido-Neyoy ME; Martínez-Soriano PA; Ruiz-Sánchez MB; Angeles E; Villa-Treviño S
    Anticancer Drugs; 2013 Apr; 24(4):394-405. PubMed ID: 23388162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of preneoplastic rat liver lesions with an attenuated p53 response by low doses of diethylnitrosamine.
    Silins I; Stenius U; Högberg J
    Arch Toxicol; 2004 Sep; 78(9):540-8. PubMed ID: 15340777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The expression of mutant p53 (mp53) protein in rat hepatic preneoplastic lesions induced by diethylnitrosamine (DEN)].
    Zhu H; Zhang X; Chen Y
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):22-4. PubMed ID: 10743048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathology of early stage chemically induced hepatocarcinogenesis.
    Ogawa K
    Pathol Int; 2009 Sep; 59(9):605-22. PubMed ID: 19712128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low selection of preneoplastic hepatocytes after treatment with the 2-acetylaminofluorene diet-partial hepatectomy regimen in the liver of hepatocarcinogenesis-resistant DRH strain rats.
    Imai K; Yamamoto M; Tanaka H; Hashimoto N; Miyakoshi M; Honmou S; Yoshie M; Tamakawa S; Yaginuma Y; Kasai S; Ogawa K
    Oncol Rep; 2007 Jan; 17(1):55-60. PubMed ID: 17143478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of nuclear p53 protein in preneoplastic rat hepatocytes is accompanied by Mdm2 and Bcl-2 overexpression and by defective response to DNA damage in vivo.
    Van Gijssel HE; Ohlson LC; Torndal UB; Mulder GJ; Eriksson LC; Porsch-Hällström I; Meerman JH
    Hepatology; 2000 Oct; 32(4 Pt 1):701-10. PubMed ID: 11003613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous p53-deficient (+/-) mice develop fewer p53-negative preneoplastic focal liver lesions in response to treatment with diethylnitrosamine than do wild-type (+/+) mice.
    Finnberg N; Stenius U; Högberg J
    Cancer Lett; 2004 Apr; 207(2):149-55. PubMed ID: 15072823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis.
    Cavin LG; Venkatraman M; Factor VM; Kaur S; Schroeder I; Mercurio F; Beg AA; Thorgeirsson SS; Arsura M
    Cancer Res; 2004 Oct; 64(19):7030-8. PubMed ID: 15466196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation during early hepatocarcinogenesis: cellular and molecular effects.
    Chagas CE; Bassoli BK; de Souza CA; Deminice R; Jordão Júnior AA; Paiva SA; Dagli ML; Ong TP; Moreno FS
    Int J Cancer; 2011 Nov; 129(9):2073-82. PubMed ID: 21480218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Naphthoflavone enhances oxidative stress responses and the induction of preneoplastic lesions in a diethylnitrosamine-initiated hepatocarcinogenesis model in partially hepatectomized rats.
    Dewa Y; Nishimura J; Muguruma M; Jin M; Saegusa Y; Okamura T; Tasaki M; Umemura T; Mitsumori K
    Toxicology; 2008 Feb; 244(2-3):179-89. PubMed ID: 18164116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.